Cardiol Therapeutics Inc. (CRDL) — research page
US · us-cm-kg/NASDAQ/CRDL · as of 2026-11-08
Identity and listing
The issuer is Cardiol Therapeutics Inc., listed on NASDAQ under ticker CRDL with ISIN US14161Y2000. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-A6). Its security type is non-operating entity type (other), its segment is not on the record, and its sector is 2836 Biological Products, (No Diagnostic Substances). Its jurisdiction is Ontario, Canada, and its status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Cardiol Therapeutics Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CRDL | source · 2026-11-08 |
| ISIN | US14161Y2000 | source · 2026-10-13 |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | Ontario, Canada | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 42 filings across 34 filing days in the window from 2025-11-08 to 2026-11-08, comprising 2 prospectus, 7 regulatory filing and 33 results filings. The median gap between filing days is 7 days. The latest filing is a results filing dated 2026-11-03, which is 5 days before the record date of 2026-11-08. The exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days across 4,359 NASDAQ issuers. The sector median is 65.5 filings, a cadence gap of 5.5 days and a latency of 4.0 days across 176 issuers in 2836 Biological Products, (No Diagnostic Substances). The issuer's 42 filings sit below the exchange median of 52 and below the sector median of 65.5.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 42 | 7 | 5 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-03 | results | 6-K | 6-K — FORM 6-K |
| 2026-11-03 | results | 6-K | 6-K — FORM 6-K |
| 2026-11-03 | regulatory_filing | SUPPL | SUPPL — SUPPL |
| 2026-09-23 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-09-23 | results | 6-K | 6-K — FORM 6-K |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover, as foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.
Orderability
The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read. The count is 0.
Open research
No openly published research notes were found on the record. The count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001702123.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/CRDL (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://mcp.us-cm-kg.ai/record/NASDAQ/CRDL (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US14161Y2000"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:47e322442bbf5c9c.